High mortality in patients with Mycobacterium avium complex lung disease: a systematic review
Open Access
- 2 May 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 18 (1), 1-10
- https://doi.org/10.1186/s12879-018-3113-x
Abstract
Background: The incidence of nontuberculous mycobacterial (NTM) pulmonary disease caused by Mycobacterium avium complex (MAC) in apparently immune-competent people is increasing worldwide. We performed a systematic review of the published literature on five-year all-cause mortality in patients with MAC lung disease, and pooled the mortality rates to give an overall estimate of five-year mortality from these studies. Methods: We systematically reviewed the literature up to 1st August 2017 using PubMed (R) and ProQuest Dialog (TM) to search Medline (R) and Embase (R) databases, respectively. Eligible studies contained > 10 patients with MAC, and numerical five-year mortality data or a treatment evaluation for this patient group. Mortality data were extracted and analysed to determine a pooled estimate of all-cause mortality. Results: Fourteen of 1035 identified studies, comprising 17 data sets with data from a total of 9035 patients, were eligible. The pooled estimate of five-year all-cause mortality was 27% (95% CI 21.3-37.8%). A high degree of heterogeneity was observed (I-2 = 96%). The mortality in the data sets varied between 10 and 48%. Studies predominantly including patients with cavitary disease or greater comorbidity reported a higher risk of death. Patients in Asian studies tended to have a lower mortality risk. Predictors of mortality consistent across studies included male sex, presence of comorbidities and advanced patient age. Conclusions: Despite high heterogeneity, most studies in patients with MAC pulmonary disease document a five-year all-cause mortality exceeding 25%, indicating poor prognosis. These findings emphasise the need for more effective management and additional prospective mortality data collection.Keywords
This publication has 32 references indexed in Scilit:
- Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- A Steady Increase in Nontuberculous Mycobacteriosis Mortality and Estimated Prevalence in JapanAnnals of the American Thoracic Society, 2014
- Prognostic Factors and Radiographic Outcomes of Nontuberculous Mycobacterial Lung Disease in Rheumatoid ArthritisThe Journal of Rheumatology, 2013
- Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare BeneficiariesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Therapy of refractory nontuberculous mycobacterial lung diseaseCurrent Opinion in Infectious Diseases, 2012
- Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Nontuberculous Pulmonary Mycobacteriosis in DenmarkAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapyThorax, 2008
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov.International Journal of Systematic and Evolutionary Microbiology, 2004